1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
Direct Link:
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Original Article
You have full text access to this OnlineOpen article
Determinants of outcome of compensated hepatitis C virus-related cirrhosis
Article first published online: 30 DEC 2003
DOI: 10.1002/hep.510270535
Copyright © 1998 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Serfaty, L., Aumaître, H., Chazouillères, O., Bonnand, A.-M., Rosmorduc, O., Poupon, R. E. and Poupon, R. (1998), Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology, 27: 1435–1440. doi: 10.1002/hep.510270535
Publication History
- Issue published online: 30 DEC 2003
- Article first published online: 30 DEC 2003
- Manuscript Accepted: 13 FEB 1998
- Manuscript Received: 13 OCT 1997
- Abstract
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , Anticarcinogenic impact of interferon therapy on the progression of hepatocellular carcinoma in patients with chronic viral infection, Hepatology Research, 2012, 42, 1
- 2, , , , , , , , , , , , , , , APASL consensus statements and management algorithms for hepatitis C virus infection, Hepatology International, 2012, 6, 2, 409
- 3, , , , , , , Elevated frequency and function of regulatory T cells in patients with active chronic hepatitis C, Journal of Gastroenterology, 2012,
- 4, , , Indicaciones actuales de tratamiento triple para la hepatitis C, GastroenterologÃa y HepatologÃa, 2012, 35, 4, 266
- 5, , , , , , , , The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam, Addiction, 2012, 107, 3Direct Link:
- 6, , , , , , , , , , , , , , , , , A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C, Hepatology, 2011, 54, 2Direct Link:
- 7, , , , , Eradication of Hepatitis C Virus Reduces the Risk of Hepatocellular Carcinoma in Patients with Compensated Cirrhosis, Digestive Diseases and Sciences, 2011, 56, 6, 1853
- 8, , Fibrosis in chronic viral hepatitis, Best Practice & Research Clinical Gastroenterology, 2011, 25, 2, 219
- 9, , , , , , , , , , , , Importance of Medication Adherence to Peginterferon-Ribavirin Combination Therapy in Patients with Chronic Hepatitis C, The Korean Journal of Gastroenterology, 2011, 57, 5, 294
- 10, , Managing patients with hepatitis-B-related or hepatitis-C-related decompensated cirrhosis, Nature Reviews Gastroenterology & Hepatology, 2011, 8, 5, 285
- 11, , , , , , , , , , , Portal Pressure Predicts Outcome and Safety of Antiviral Therapy in Cirrhotic Patients With Hepatitis C Virus Infection, Clinical Gastroenterology and Hepatology, 2011, 9, 7, 602
- 12, , , , , The Impact of Antiviral Therapy and the Influence of Metabolic Cofactors on the Outcome of Chronic HCV Infection, International Journal of Hepatology, 2011, 2011, 1
- 13, , , , , , , Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus–Related Cirrhosis, Clinical Gastroenterology and Hepatology, 2010, 8, 2, 192
- 14, , , , , , , , , , , , , , , , , , , , , , , , , Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma, Hepatology International, 2010, 4, 2, 439
- 15, , Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well do they predict clinical outcomes?, Current Opinion in HIV and AIDS, 2010, 5, 6, 517
- You have free access to this content16Chapter 1: Prevention, Hepatology Research, 2010, 40,Direct Link:
- 17, , Does chemotherapy prevent HCV-related hepatocellular carcinoma? Cons, Digestive and Liver Disease, 2010, 42, S287
- 18, , Editorial: Treatment of Patients With HCV-Related Cirrhosis With Peginterferon and Ribavirin: Swinging the Pendulum Toward Treatment, The American Journal of Gastroenterology, 2010, 105, 10, 2174
- 19, , , , , , , , , , , Intermediate Hepatobiliary Cells Predict an Increased Risk of Hepatocarcinogenesis in Patients With Hepatitis C Virus-Related Cirrhosis, Gastroenterology, 2010, 139, 1, 335
- 20, , , , , , , , , , , , Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing, Journal of Hepatology, 2010, 53, 4, 616
- 21, , , , , , Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy, European Journal of Gastroenterology & Hepatology, 2010, 22, 4, 474
- 22, , , , , , , , , , , , , , , , Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response, The American Journal of Gastroenterology, 2010, 105, 10, 2164
- 23, , , , , , , , , , , , , , Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis C, Gastroenterology, 2010, 138, 1, 136
- 24, , , , Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection, Alimentary Pharmacology & Therapeutics, 2010, 32, 3Direct Link:
- 25
- 26
- 27
- 28, , , , , , , , , Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient, Transplant International, 2009, 22, 2Direct Link:
- 29, , , , , , , , , Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis, Journal of Gastroenterology and Hepatology, 2009, 24, 7Direct Link:
- 30, , , , , , , , Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores, Journal of Hepatology, 2009, 50, 1, 59
- 31, , , , , Factors Associated With Hepatic Fibrosis In Patients With Chronic Hepatitis C, Journal of Clinical Gastroenterology, 2009, 43, 8, 758
- 32, , , , Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis, Journal of Hepatology, 2009, 50, 6, 1142
- 33, , , , Hepatitis C virus-induced hepatocarcinogenesis, Journal of Hepatology, 2009, 51, 4, 810
- 34, , , , , , , , , Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France, Hepatology, 2009, 50, 5Direct Link:
- 35, , , , Parenchymal Extinction: Coagulation and Hepatic Fibrogenesis, Clinics in Liver Disease, 2009, 13, 1, 117
- 36, Prevention of cancer recurrence after treatment for hepatitis C virus-related hepatocellular carcinoma by interferon therapy, Clinical Journal of Gastroenterology, 2009, 2, 2, 65
- 37
- 38, , , , , , , , , The natural history of hepatitis C cirrhosis after liver transplantation, Liver Transplantation, 2009, 15, 9Direct Link:
- 39, , Treatment of hepatitis C in the potential liver transplant recipient, Current Hepatitis Reports, 2009, 8, 2, 81
- 40, , , , , , , , , A case of Child-Pugh class B cirrhosis in hepatitis C infection successfully treated with interferon beta after balloon-occluded retrograde transvenous obliteration for gastric varices, Kanzo, 2008, 49, 7, 307
- 41, , , , Cost-Effectiveness of the National Screening Program for Hepatitis C Virus in the General Population and the High-Risk Groups, The Tohoku Journal of Experimental Medicine, 2008, 215, 1, 33
- 42, , , , , , , , , , Distribution of hepatitis C virus genotypes in Jeju Island, The Korean Journal of Hepatology, 2008, 14, 1, 28
- 43, , , , Economic impact of extended treatment with peginterferon α-2a and ribavirin for slow hepatitis C virologic responders, Journal of Viral Hepatitis, 2008, 15, 4Direct Link:
- 44, , , , , , , , , , Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection, The Korean Journal of Hepatology, 2008, 14, 3, 318
- 45, , , , Factors Influencing Hepatitis C Virus Sero-prevalence among Blood Donors in North West Pakistan, Journal of Public Health Policy, 2008, 29, 2, 207
- 46, , , , , , , , Hepatitis B Virus DNA in Liver Tissue and Risk for Hepatocarcinogenesis in Patients with Hepatitis C Virus-Related Chronic Liver Disease, Intervirology, 2008, 51, 1, 59
- 47, , , , , , , , Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C, Virology, 2008, 375, 2, 580
- 48, , , , , , , , , , Impact of viral eradication on mortality related to hepatitis C: A modeling approach in France, Journal of Hepatology, 2008, 49, 2, 175
- 49
- 50, , , , , , , , , , , , , , , , Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases, Journal of Gastroenterology, 2008, 43, 9, 720
- 51Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection, Journal of Gastroenterology and Hepatology, 2007, 22, 5Direct Link:
- 52, , , , , , Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?, Journal of Viral Hepatitis, 2007, 14, 3Direct Link:
- 53, , , , , , , , , , , , , , , , Effect of Prolonged Interferon Therapy on the Outcome of Hepatitis C Virus–Related Cirrhosis: A Randomized Trial, Clinical Gastroenterology and Hepatology, 2007, 5, 4, 502
- 54, , Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis, Gastroenterology, 2007, 132, 7, 2557
- 55, , , , , , , , , , , , , Long-Term Outcome after Interferon Therapy in Elderly Patients with Chronic Hepatitis C, Intervirology, 2007, 50, 1, 16
- 56, , , , , , , , Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: A randomized controlled trial, Journal of Hepatology, 2007, 47, 4, 484
- 57, , , , , The cost-effectiveness of the new protocol reflecting rapid virologic response to peginterferon ??-2b and ribavirin for chronic hepatitis C, European Journal of Gastroenterology & Hepatology, 2007, 19, 9, 733
- 58, , , , , , , , , The natural history of hepatitis C with severe hepatic fibrosis, Journal of Hepatology, 2007, 47, 1, 37
- 59, , , , , , , , , Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases, Hepatology, 2006, 44, 6Direct Link:
- 60, , , , , , , , , , , , , , Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 μg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis, Journal of Viral Hepatitis, 2006, 13, 7Direct Link:
- 61, , , , , , , , Hépatite C et transplantation hépatique, Gastroentérologie Clinique et Biologique, 2006, 30, 11, 1281
- 62, , , , , , , , , , , , , HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon α-2a and ribavirin, Journal of Viral Hepatitis, 2006, 13, 11Direct Link:
- 63
- 64, , , Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies, Journal of Hepatology, 2006, 44, 1, 217
- 65, , , , , , , , , , , , Natural history of compensated cirrhosis in the Child-Pugh class a compared between 490 patients with hepatitis C and 167 with B virus infections, Journal of Medical Virology, 2006, 78, 4Direct Link:
- 66, , Palliative Care for Patients with End-Stage Liver Disease Ineligible for Liver Transplantation, Gastroenterology Clinics of North America, 2006, 35, 1, 201
- 67, , Peginterferon-α2ain the treatment of chronic hepatitis C, Future Virology, 2006, 1, 6, 689
- 68, , , , , , Results of combination treatment with pegylated interferon and ribavirin in cirrhotic patients with hepatitis C infection, Liver International, 2006, 26, 6Direct Link:
- 69, , The Changing Epidemiology and Natural History of Hepatitis C Virus Infection, Clinics in Liver Disease, 2006, 10, 4, 697
- 70, Traitements antiviraux au cours de la cirrhose virale C, Gastroentérologie Clinique et Biologique, 2006, 30, 6-7, 899
- 71, , , Treatment of Hepatitis C Infection, Gastroenterology Clinics of North America, 2006, 35, 2, 463
- 72, Antiviral therapy in the liver transplant candidate and recipient, Current Hepatitis Reports, 2005, 4, 2, 75
- 73, , , Effect of Long-Term Postoperative Interferon Therapy on Intrahepatic Recurrence and Survival Rate after Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma, Intervirology, 2005, 48, 1, 71
- 74, , , , , , , Identification of Chronic Hepatitis B Patients without Significant Liver Fibrosis by a Simple Noninvasive Predictive Model, The American Journal of Gastroenterology, 2005, 100, 3, 616
- 75, , Influence of Recent Advances in Medical Management on Clinical Outcomes of Cirrhosis, Mayo Clinic Proceedings, 2005, 80, 11, 1501
- 76, , , , , , , Lower incidence of hepatic failure than hepatocellular carcinoma in Japanese patients with chronic Hepatitis C, Liver International, 2005, 25, 4Direct Link:
- 77, Management of cirrhosis due to chronic hepatitis C, Journal of Hepatology, 2005, 42, 1, S65
- 78
- 79, , , , , , , , , Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis, Journal of Viral Hepatitis, 2005, 12, 4Direct Link:
- 80, , , , , , , , , , , , Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosis, Gastroentérologie Clinique et Biologique, 2005, 29, 4, 347
- 81, Should we treat patients with chronic hepatitis C on the waiting list?, Journal of Hepatology, 2005, 42, 4, 456
- 82, Therapeutic modalities in hepatitis C: challenges and development, Journal of Viral Hepatitis, 2005, 12, 1Direct Link:
- 83, , , , , , , Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy, Hepatology, 2005, 42, 2Direct Link:
- 84, , Treatment of HCV infection with pegylated interferons, Current Hepatitis Reports, 2005, 4, 2, 49
- 85, , Treatment of hepatitis C, Journal of Viral Hepatitis, 2005, 12, 3Direct Link:
- 86, Treatment of Hepatitis C after Liver Transplantation, Clinics in Liver Disease, 2005, 9, 4, 579
- 87, Treatment of Hepatitis C in Patients Who Have Decompensated Cirrhosis, Clinics in Liver Disease, 2005, 9, 3, 473
- 88
- 89, , , , , Biomedicines to reduce inflammation but not viral load in chronic HCV – what's the sense?, Trends in Biotechnology, 2004, 22, 10, 517
- 90, , , , Cirrosis hepática, Medicine - Programa de Formación Médica Continuada Acreditado, 2004, 9, 8, 489
- 91
- 92, , , , , , Comparison of long-term effects of lymphoblastoid interferon alpha and recombinant interferon alpha-2a therapy in patients with chronic hepatitis B, Journal of Viral Hepatitis, 2004, 11, 4Direct Link:
- 93, , , , , , , , , , , Effects of Interferon Treatment Response on Liver Complications of Chronic Hepatitis C: 9-year Follow-Up Study, The American Journal of Gastroenterology, 2004, 99, 4, 636
- 94, , , , Hepatocellular carcinoma in cirrhosis: Incidence and risk factors, Gastroenterology, 2004, 127, 5, S35
- 95, , , , , , , , , , , , , , , , Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death, Journal of Viral Hepatitis, 2004, 11, 2Direct Link:
- 96, , Pathogenesis of hepatitis C—associated hepatocellular carcinoma, Gastroenterology, 2004, 127, 5, S62
- 97, , , , , , , , , , , , , , , , , , Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy, Liver International, 2004, 24, 6Direct Link:
- 98, , Treatment of chronic HCV infection in compensated and decompensated cirrhosis, Journal of Gastroenterology and Hepatology, 2004, 19,Direct Link:
- 99, What is the nature of the problem?, Journal of Viral Hepatitis, 2004, 11,Direct Link:
- 100, An evidence-based approach to studies in cirrhosis and portal hypertension: medical management of mild to moderate ascites, Clinical Gastroenterology and Hepatology, 2003, 1, 6, 474
- 101, , Pathophysiology of Hepatitis C and HIV Coinfection, Journal of the Association of Nurses in AIDS care, 2003, 14, 5, 27S
- 102, , , , Predicting progression to cirrhosis in chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2003, 10, 4Direct Link:
- 103, , , , Recent patents on experimental therapy for hepatitis C virus infection (1999 – 2002), Expert Opinion on Therapeutic Patents, 2003, 13, 11, 1707
- 104, , Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes, Clinics in Liver Disease, 2003, 7, 3, 683
- 105, Treatment Considerations in Patients With Hepatitis C and Cirrhosis, Journal of Clinical Gastroenterology, 2003, 37, 5, 395
- 106, , Treatment of chronic hepatitis C in nonresponders to previous therapy, Current Gastroenterology Reports, 2003, 5, 1, 78
- 107, , Treatment strategies for hepatitis C: intervention prior to liver transplant, pre-emptively or after established disease, Clinics in Liver Disease, 2003, 7, 3, 631
- 108, , , Factors predictive of death among HIV-uninfected persons with haemophilia and other congenital coagulation disorders, Haemophilia, 2002, 8, 5Direct Link:
- 109, Hepatocellular carcinoma and hepatitis C in the United States, Hepatology, 2002, 36, S1Direct Link:
- 110, , , , , , , , , , Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C, Cancer, 2002, 95, 2Direct Link:
- 111, , , , Is severe liver disease a common outcome for people with chronic hepatitisC?, Journal of Gastroenterology and Hepatology, 2002, 17, 4Direct Link:
- 112, , Place des interférons dans le traitement des infections par les virusde l'hépatite B et de l'hépatite C, La Revue de Médecine Interne, 2002, 23, 459S
- 113, , Role of Antiviral Therapy in the Prevention of Hepatocellular Carcinoma, Journal of Vascular and Interventional Radiology, 2002, 13, 9, S191
- 114, , , An emerging role for interferon in haemophiliacs with chronic hepatitis C?, Haemophilia, 2001, 7, 1Direct Link:
- 115, , , An emerging role for interferon in haemophiliacs with chronic hepatitis C?, Haemophilia, 2001, 7, 1, 6
- 116, , , Chemoprevention of hepatocellular carcinoma: Concept, progress and perspectives, Journal of Gastroenterology and Hepatology, 2001, 16, 12Direct Link:
- 117
- 118, Effect of HCV viral dynamics on treatment design: lessons learned from HIV, The American Journal of Gastroenterology, 2001, 96, 10, 2818
- 119, , , Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis, Alimentary Pharmacology & Therapeutics, 2001, 15, 5Direct Link:
- 120, , , , , , , GUIDELINES FOR THE REFERRAL AND MANAGEMENT OF PATIENTS ELIGIBLE FOR SOLID ORGAN TRANSPLANTATION, Transplantation, 2001, 71, 9, 1189
- 121, , Hepatitis C and hepatocellular carcinoma, Current Treatment Options in Oncology, 2001, 2, 6, 473
- 122
- 123
- 124, , , , , , , , , , , , , , , , , , , Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe, Journal of Viral Hepatitis, 2001, 8, 3Direct Link:
- 125
- 126
- 127, , , , Immunopathogenesis of hepatitis C virus infection, Immunology and Cell Biology, 2001, 79, 6, 515
- 128, , , , Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach, Journal of Hepatology, 2001, 34, 4, 593
- 129, , , , , , , Japan-specific subtype of hepatitis C virus genotype 1b, J subtype, has relatively low pathogenicity, Journal of Medical Virology, 2001, 65, 1Direct Link:
- 130, , Locoregional Management of Hepatocellular Carcinoma, Clinics in Liver Disease, 2001, 5, 1, 161
- 131, , , , , , , , , , , Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C, Journal of Hepatology, 2001, 34, 5, 748
- 132, , , Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention, Expert Review of Anticancer Therapy, 2001, 1, 2, 277
- 133, Models predicting the natural history of cirrhosis and need for liver transplantation, Current Opinion in Organ Transplantation, 2001, 6, 2, 107
- 134, , Natural history of chronic hepatitis C: Identifying a window of opportunity for intervention, Disease-a-Month, 2001, 47, 12, 593
- 135, , The cost of hepatitis C and the cost–effectiveness of its prevention, Health Policy, 2001, 58, 2, 121
- 136, , Therapeutic advances in the management of hepatitis B and hepatitis C, Current Opinion in Infectious Diseases, 2001, 14, 5, 593
- 137, , , Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection, Journal of Viral Hepatitis, 2001, 8, 1, 1
- 138, , , Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection, Journal of Viral Hepatitis, 2001, 8, 1Direct Link:
- 139, , , Antiviral Therapy of HBV- and HCV-induced Liver Cirrhosis, Journal of Clinical Gastroenterology, 2000, 30, 3, 234
- 140, Asian perspectives on viral hepatitis: Hepatitis C virus infection, Journal of Gastroenterology and Hepatology, 2000, 15,Direct Link:
- 141, , , , , , , , Combined treatment of relapse of chronic hepatitis C with high-dose α2b interferon plus ribavirin for 6 or 12 months, Journal of Hepatology, 2000, 33, 3, 456
- 142, , , Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C, The American Journal of Medicine, 2000, 108, 5, 366
- 143, , , , , , , , , , , , , Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: A retrospective cohort study of 738 patients, International Journal of Cancer, 2000, 87, 5Direct Link:
- 144, , Liver transplantation for hepatitis C virus related cirrhosis, Best Practice & Research Clinical Gastroenterology, 2000, 14, 2, 307
- 145, , Long-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C, Journal of Gastroenterology and Hepatology, 2000, 15,Direct Link:
- 146, , Natural history of chronic hepatitis C, Journal of Gastroenterology and Hepatology, 2000, 15,Direct Link:
- 147, , Predictors of the efficacy of interferon therapy for patients with chronic hepatitis C before and during therapy: how does this modify the treatment course?, Journal of Gastroenterology and Hepatology, 2000, 15,Direct Link:
- 148, , , , , , , , The effect of retreatment with interferon-α on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C, Cancer, 2000, 88, 1Direct Link:
- 149
- 150, , , , , , , , , , , Which patients with hepatitis C develop liver complications?, Hepatology, 2000, 31, 2Direct Link:
- 151, , Clinical significance of hepatitis C virus genotypes, Journal of Hepatology, 1999, 31, 65
- 152, , Early predictors of response to treatment in patients with chronic hepatitis C, Journal of Hepatology, 1999, 31, 237
- 153, , , , , EFFECT OF INTERFERON THERAPY ON THE NATURAL HISTORY OF HEPATITIS C VIRUS-RELATED CIRRHOSIS AND HEPATOCELLULAR CARCINOMA, Clinics in Liver Disease, 1999, 3, 4, 869
- 154, , , , , Effects of interferon therapy in “non responder†patients with chronic hepatitis C, Journal of Hepatology, 1999, 31, 178
- 155, FACTORS CONTRIBUTING TO THE EVOLUTION AND OUTCOME OF CIRRHOSIS IN HEPATITIS C, Clinics in Liver Disease, 1999, 3, 4, 741
- 156, , Hepatitis C virus: current understanding and prospects for future therapies, Molecular Medicine Today, 1999, 5, 9, 393
- 157
- 158, Hepatocellular carcinoma after sustained response to interferon in non-cirrhotic hepatitis C: Flaws in the cure, or a clue to the flaws?, Journal of Gastroenterology and Hepatology, 1999, 14, 9Direct Link:
- 159, , , Long-Term Interferon Alpha Maintenance Therapy for Chronic Hepatitis C Infection in a Patient With Common Variable Immune Deficiency, Journal of Clinical Gastroenterology, 1999, 29, 2, 203
- 160, , , , , Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection, Hepatology, 1999, 29, 3Direct Link:
- 161, , , , , , , , Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease, Liver, 1999, 19, 5Direct Link:
- 162, , , , Modeling the hepatitis C virus epidemic in france, Hepatology, 1999, 29, 5Direct Link:
- 163
- 164, , , , , , Prognostic usefulness of ultrasonographic signs of portal hypertension in patients with Child-Pugh stage A liver cirrhosis, The American Journal of Gastroenterology, 1999, 94, 12, 3595
- 165, , Rising Incidence of Hepatocellular Carcinoma in the United States, New England Journal of Medicine, 1999, 340, 10, 745
- 166, , , , , , , , , Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study, Australian and New Zealand Journal of Medicine, 1999, 29, 3Direct Link:
- 167, , The long-term outcomes of patients with compensated hepatitis C virus–related cirrhosis and history of parenteral exposure in the united states, Hepatology, 1999, 29, 4Direct Link:
- 168, , , , , , , , , , , , Treatment of hepatitis C virus–related cirrhosis: A randomized, controlled trial of interferon alfa-2b versus no treatment, Hepatology, 1999, 29, 6Direct Link:
- 169, , , , , , , Treatment of patients with chronic hepatitis C and cirrhosis, Journal of Hepatology, 1999, 31, 197
- 170, , TREATMENT STRATEGIES FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION, Clinics in Liver Disease, 1999, 3, 4, 883
- 171
- 172, , Hepatitis C: Somber views of natural history and optimistic views of interferon treatment?, Hepatology, 1998, 27, 5Direct Link: